Chargement en cours...

Long-term use of 0.003% tacrolimus suspension for treatment of vernal keratoconjunctivitis

PURPOSE: To evaluate the safety and efficacy of 0.003% tacrolimus suspension for the treatment of refractory vernal keratoconjunctivitis (VKC). MATERIALS AND METHODS: This prospective study included 40 eyes of 20 patients with severe VKC. After discontinuing all other medications, patients were trea...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oman J Ophthalmol
Auteurs principaux: Al-Amri, Abdulrahman Mohammed, Fiorentini, Sandra Flavia, Albarry, Maan A., Bamahfouz, Ashjan Yousef
Format: Artigo
Langue:Inglês
Publié: Medknow Publications & Media Pvt Ltd 2017
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5657154/
https://ncbi.nlm.nih.gov/pubmed/29118487
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/ojo.OJO_232_2014
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!